J A Slack
Impact in
Papers in
-
- Cancer therapeutics and mechanisms 7
- Oncology 7
- Cancer Treatment and Pharmacology 4
- Co-authors
- Malcolm F. G. Stevens (2 shared papers)B.J. Denny (1 shared paper)Richard T. Wheelhouse (1 shared paper)C Goddard (4 shared papers)M. F. G. STEVENS (6 shared papers)Andreas Gescher (3 shared papers)Daniel Chubb (1 shared paper)J A Hickman (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (3 papers)Journal of Chromatography A (3 papers)Journal of Pharmacy and Pharmacology (2 papers)British Journal of Cancer (2 papers)Drug Metabolism and Disposition (2 papers)
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
J A Slack
30 papers receiving 1.1k citations
J A Slack's Hit Papers
Peers
Comparison fields: 5 of 104
- Genetics 401
- Oncology 307
- Cancer Research 153
- Molecular Biology 531
- Pharmacology 64
Countries citing papers authored by J A Slack
This map shows the geographic impact of J A Slack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Slack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Slack more than expected).
Fields of papers citing papers by J A Slack
This network shows the impact of papers produced by J A Slack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Slack. The network helps show where J A Slack may publish in the future.
Co-authors
The 25 scholars most cited alongside J A Slack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 348 | |
| 2 | Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine. Hit paper breakdown → | 1987 | 335 |
| 3 | 1991 | 78 | |
| 4 | 1990 | 54 | |
| 5 | Phase I clinical trial of mitozolomide. | 1985 | 39 |
| 6 | 1978 | 31 | |
| 7 | 1996 | 27 | |
| 8 | 1995 | 20 | |
| 9 | 1992 | 18 | |
| 10 | 1988 | 16 | |
| 11 | 1985 | 15 | |
| 12 | 1979 | 14 | |
| 13 | 1988 | 13 | |
| 14 | Studies of the pharmacology of N-methylformamide in mice. | 1982 | 13 |
| 15 | 1977 | 13 | |
| 16 | 1985 | 12 | |
| 17 | 1989 | 11 | |
| 18 | 1986 | 10 | |
| 19 | 1980 | 9 | |
| 20 | 1981 | 7 |
About J A Slack
J A Slack is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Pharmacology and Pharmacology, having authored 30 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Synthesis and Characterization of Heterocyclic Compounds (5 papers), Cancer Treatment and Pharmacology (4 papers), Chemical Reactions and Isotopes (3 papers), Analytical Chemistry and Chromatography (3 papers), Synthesis and biological activity (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Genetics (401 citations), Oncology (307 citations), Cancer Research (153 citations), Molecular Biology (531 citations) and Pharmacology (64 citations). J A Slack has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include Malcolm F. G. Stevens, B.J. Denny, Richard T. Wheelhouse, C Goddard, M. F. G. STEVENS, Andreas Gescher, Daniel Chubb, J A Hickman, Neil W. Gibson and R. L. Stone. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Chromatography A, Journal of Pharmacy and Pharmacology, British Journal of Cancer and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.